|View printer-friendly version|
|Amneal and Intrexon Enter into Exclusive Channel Collaboration to Improve Active Pharmaceutical Ingredient Production|
The vast majority of active pharmaceutical ingredients are currently produced through a series of complex chemical processes. The goal of the collaboration is to develop a biological process for a targeted API production that may reduce the cost of production. The collaboration will leverage
Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.
For more information contact:
Intrexon Corporation Contacts:
|Print Page | E-mail Page | RSS Feeds | | E-mail Alerts | Contact US | Financial Tear Sheet|